General Information of the Compound
| Compound ID |
CP0236526
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[(5S)-5-[2-methyl-1-oxo-1-(1,3,4-thiadiazol-2-ylamino)propan-2-yl]-5H-chromeno[2,3-b]pyridin-2-yl]benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H21N5O3S
|
||||||||||||||||||
| Molecular Weight |
471.542
|
||||||||||||||||||
| Canonical SMILES |
CC(C)([C@H]1c2ccccc2Oc2nc(ccc12)-c1ccc(cc1)C(N)=O)C(=O)Nc1nncs1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H21N5O3S/c1-25(2,23(32)29-24-30-27-13-34-24)20-16-5-3-4-6-19(16)33-22-17(20)11-12-18(28-22)14-7-9-15(10-8-14)21(26)31/h3-13,20H,1-2H3,(H2,26,31)(H,29,30,32)/t20-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
GUNFJNSLSUWRPU-FQEVSTJZSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00967, Glucocorticoid receptor